Key result
Evening dosing optimizes short-acting statins, whereas long-acting statins allow flexible timing to support adherence.
Answers are grounded in this paper and cite their sources.
PURPOSE OF REVIEW: In humans, cholesterol biosynthesis varies diurnally, reaching its peak at night. Therefore, choosing the time of statin administration is critical because of their different half-lives. Dose timing becomes more important in patients with polypharmacy because it might affect their adherence to the statin therapy. RECENT FINDINGS: Herein, we narratively summarized the available clinical studies (n = 17) and meta-analyses (n = 2) that compared the morning with the evening dose of statins in terms of safety and efficacy, with special focus on their low-density lipoprotein-lowering effects. We also explained the difference in efficacy results in case of short-acting compared with the long-acting statins and highlighted how flexibility in choosing the time of statin administration is important for better adherence. SUMMARY: The current limited evidence suggests that short-acting statins should be given in the evening whereas long-acting statins could be given at any time of the day with allowing more patient-based choice (of timing) for better adherence. Lager RCTs with longer durations are recommended to extend and confirm the current evidence.
No takes yet. Share an insight, caveat, or question.
Awad et al. (2018) conducted a review in Dyslipidemia / Hypercholesterolemia. Morning statin administration vs. Evening statin administration was evaluated on Low-density lipoprotein-lowering efficacy and safety. Across 17 clinical studies and 2 meta-analyses, short-acting statins should be administered in the evening, whereas long-acting statins can be taken at any time of day to improve adherence.
Synapse has enriched 10 related papers. Consider them for comparative context: